Veterinary Medicines

Nobivac KC nasal drops, lyophilisate and solvent for suspension for dogs

Authorised
  • Bordetella bronchiseptica, strain B-C2, Live
  • Canine parainfluenza virus, strain Cornell, Live
Download as PDF

Product identification

Medicine name:
Nobivac KC nasal drops, lyophilisate and solvent for suspension for dogs
Nobivac KC vet. Frystorkat pulver och vätska till näsdroppar, suspension
Active substance:
  • Bordetella bronchiseptica, strain B-C2, Live
  • Canine parainfluenza virus, strain Cornell, Live
Target species:
  • Dog
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain B-C2, Live
    9.70
    log10 colony forming unit(s)
    /
    0.40
    millilitre(s)
  • Canine parainfluenza virus, strain Cornell, Live
    5.80
    log10 50% tissue culture infectious dose
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Nasal spray, lyophilisate and solvent for suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AF
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:
  • Cardboard or plastic boxes with 50 glass (tiype I) vial closed with a halogenobutyl rubber stopper and aluminium cap, 25 x 1 dose of vaccine and solvent
  • Cardboard or plastic boxes with 10 glass (tiype I) vial closed with a halogenobutyl rubber stopper and aluminium cap, 5 x 1 dose of vaccine and solvent

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 25263
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0134/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Ireland
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 13/02/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 21/02/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 21/02/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 21/02/2024
Download